KKR & Co. Inc.

(New York Stock Exchange)
Neutral +10

FS KKR (NYSE: FSK) amends 14D-9 after $150M KKR tender expires - Stock Titan

πŸ“… FS KKR filed Amendment No. 5 to its Schedule 14D-9 following the expiration of a tender offer on June 11, 2026.

πŸ’° KKR Alternative Assets L.P. purchased 13,636,363 shares at $11.00 per share for an aggregate price of $149,999,993.

πŸ“‰ The tender offer was oversubscribed, resulting in a pro rata acceptance factor of 75.779% for participating shareholders.

πŸ“œ The filing amends the original Schedule 14D-9 and related Letter of Transmittal filed on May 12, 2026.

βš–οΈ The transaction terms included a purchase price of $11.00 per share less applicable withholding taxes without interest.

Bullish Signals
  • The tender offer was oversubscribed, indicating strong shareholder interest in the acquisition at the offered price.
  • The transaction successfully closed with KKR acquiring approximately 13.6 million shares for nearly $150 million.
  • FS KKR has completed its regulatory disclosure obligations regarding the consummation of the deal.
Risk Factors
  • The pro rata acceptance factor of 75.779% means shareholders who tendered their shares received less than the full value of their holdings due to oversubscription.
  • The final results are based on advice from the Purchaser rather than an independent audit, though this is standard for such filings.
Full Analysis
FS KKR Capital Corp. (NYSE: FSK) filed Amendment No. 5 to its Schedule 14D-9 statement regarding a cash tender offer by KKR Alternative Assets L.P. The amendment confirms that the offer, which sought up to $150 million in aggregate value at $11.00 per share, expired at 11:59 p.m. New York City time on June 11, 2026. The filing discloses the final results of the transaction provided by the Purchaser. KKR Alternative Assets L.P. accepted 13,636,363 shares validly tendered for an aggregate purchase price of approximately $150 million ($149,999,993). Because the offer was oversubscribed, shares were accepted on a pro rata basis with a final proration factor of 75.779%. This regulatory filing serves as a post-offer update to inform shareholders and the market of the consummation details. It references the original Tender Offer Statement filed under Schedule TO on May 12, 2026, and incorporates prior amendments regarding the solicitation and recommendation terms.